1. Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review

   • Malvina Hoxha
   • Visar Malaj
   • Bruno Zappacosta

   Systematic Review Open access 27 January 2024 Pages: 147 - 170

   

2. A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma

   • Fei Fei Liu
   • Meaghan Bartlett
   • Samantha Craigie

   Systematic Review Open access 10 January 2024 Pages: 171 - 190

   

3. Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models

   • Tim Reason
   • William Rawlinson
   • Sven Klijn

   Original Research Article Open access 10 February 2024 Pages: 191 - 203

   

4. Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models

   • Tim Reason
   • Emma Benbow
   • Bill Malcolm

   Original Research Article Open access 10 February 2024 Pages: 205 - 220

   

5. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals

   • Jose Luis Calleja
   • Jaime Espin
   • Adam Igloi-Nagy

   Original Research Article Open access 15 December 2023 Pages: 221 - 233

   

6. Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50–85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study

   • Andrew J. Goldberg
   • Ekaterina Bordea
   • the TARVA Study Group

   Original Research Article Open access 08 January 2024 Pages: 235 - 249

   

7. From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy

   • Elvio Emanuele Rossini
   • Carlotta Galeone
   • Claudio Jommi

   Original Research Article Open access 16 January 2024 Pages: 251 - 261

   

8. Health State Utilities Associated with False-Positive Cancer Screening Results

   • Louis S. Matza
   • Timothy A. Howell
   • Karen C. Chung

   Original Research Article Open access 08 January 2024 Pages: 263 - 276

   

9. Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden

   • Maria Polyzoi
   • Mattias Ekman
   • Robert Hettle

   Original Research Article Open access 13 December 2023 Pages: 277 - 289

   

10. Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain

    • Rosa María Romero Jiménez
    • Pedro Herranz Pinto
    • Francisco José Rebollo Laserna

    Original Research Article Open access 18 January 2024 Pages: 291 - 302

    

11. An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund

    • Laura A. Trigg
    • Maxwell S. Barnish
    • Caroline Farmer

    Original Research Article Open access 12 December 2023 Pages: 303 - 311

    

12. Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark

    • Milanne Maria Johanna Galekop
    • Carin Uyl-de Groot
    • William Ken Redekop

    Original Research Article Open access 19 December 2023 Pages: 313 - 331

    

13. Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies

    • Ankita Kaushik
    • Geoffrey Dusheiko
    • Robert J. Wong

    Original Research Article Open access 03 January 2024 Pages: 333 - 343

    

14. Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy

    • Elvio Emanuele Rossini
    • Carlotta Galeone
    • Claudio Jommi

    Correction Open access 12 February 2024 Pages: 345 - 345